Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8871785 Antiviral phosphonate analogs

Patent 8871785 was granted and assigned to Gilead Sciences on October, 2014 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Gilead Sciences
Gilead Sciences
0
Date Filed
March 21, 2013
0
Date of Patent
October 28, 2014
0
Patent Applicant
Gilead Sciences
Gilead Sciences
0
Patent Application Number
13848593
0
Patent Citations Received
‌
US Patent 11801255 Lipid disulfide prodrugs and uses related thereto
‌
US Patent 11975016 2′-substituted-N
0
‌
US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment
0
‌
US Patent 11690860 Treatment of HCV infected patients with cirrhosis
0
‌
US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
0
‌
US Patent 11707480 Highly active compounds against COVID-19
0
Patent Inventor Names
Lee S. Chong
0
Maria Fardis
0
Ralph Hirschmann
0
Richard L. Mackman
0
Rosemarie O'Shea
0
Sundaramoorthi Swaninathan
0
Thorsten A. Kirschberg
0
Vidya K. Prasad
0
William A. Lee
0
William J. Watkins
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8871785
0
Patent Primary Examiner
‌
Rei Tsang Shiao
0

Find more entities like US Patent 8871785 Antiviral phosphonate analogs

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo